Cochlear

Cochlear Free Cash Flow

The Free Cash Flow (FCF) of Cochlear (COH.AX) as of Oct 13, 2026 is 306.90 M AUD. In the previous year, Free Cash Flow (FCF) was 175.20 M AUD — a change of 75.17% (higher).

Free Cash Flow

306.90 MAUD

YoY

75.17%

Last updated:

Free Cash Flow (FCF) of Cochlear is 2026 306.90 M AUD. Free Cash Flow (FCF) of Cochlear was 2025 175.20 M AUD. It decreases by 75.17% higher compared to the previous year.

The Cochlear Free Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Free Cash Flow
Date
Free Cash Flow
Jan 1, 2019
236.10 M AUD
Jan 1, 2020
-288.30 M AUD
Jan 1, 2021
198.70 M AUD
Jan 1, 2022
299.30 M AUD
Jan 1, 2023
266.50 M AUD
Jan 1, 2024
326.40 M AUD
Jan 1, 2025
175.20 M AUD
Jan 1, 2026
306.90 M AUD
The Cochlear Free Cash Flow history
YEARFree Cash FlowYoY
306.90 MAUD+75.17%
175.20 MAUD-46.32%
326.40 MAUD+22.48%
266.50 MAUD-10.96%
299.30 MAUD+50.63%
198.70 MAUD-168.92%
-288.30 MAUD-222.11%
236.10 MAUD+2.79%
229.70 MAUD+11.34%
206.30 MAUD+32.03%
156.26 MAUD-5.19%
164.80 MAUD+87.45%
87.92 MAUD—
Access this data via the Eulerpool API
Get Free API Key

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Free Cash Flow (FCF) of Cochlear is 306.90 M AUD in 2026.

Free Cash Flow (FCF) of Cochlear changed from 175.20 M AUD to 306.90 M AUD, representing a 75.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow (FCF) Cochlear since 2006 – with annual values, charts, and detailed analysis.

Free Cash Flow is the cash available after capital expenditures. It represents the cash a company can use for dividends, debt reduction, or reinvestment.

FCF = Operating Cash Flow - Capital Expenditures

Free Cash Flow (FCF)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Free Cash Flow (FCF)'s Cochlear historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Cochlear

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Cochlear